Midis clinicians are credentialed experts trained in menopause-specific healthcare
This is why it's commonly prescribed for weight loss, though that's not its intended use
Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM
Title: SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors Status: Recruiting For more information about this trial, contact: AeRang Kim, M.D., Ph.D
Aldosterone synthase inhibitors (ASIs), often regarded as the next-generation reninangiotensinaldosterone system (RAAS) blockers, work by inhibiting aldosterone synthesis at its source, thereby circumventing the escape phenomena associated with traditional approaches